According to AVROBIO's latest financial reports the company's current earnings (TTM) are $12.03 M. In 2022 the company made an earning of -$0.11 B an increase over its 2021 earnings that were of -$0.12 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $12.03 M | -111.41% |
2022 | -$0.11 B | -11.29% |
2021 | -$0.12 B | -1.15% |
2020 | -$0.13 B | 58.59% |
2019 | -$75.81 M | 63.94% |
2018 | -$46.25 M | 151.51% |
2017 | -$18.39 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -1,020.63% | ๐บ๐ธ USA |